GenScript Biotech Corp., a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies, announced an exciting investment in gene editing technology. GenScript has signed a licensing agreement with the Broad Institute of MIT to access Broad's Prime Editing technology. https://mma.prnewswire.com/media/2290287/GenScript_Logo.jpg “This partnership with the Broad Institute marks an exhilarating new chapter […]

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofSepterna, Inc. (“Septerna” or “the Company”) (NASDAQ: SEPN) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

MANSFIELD, Texas, March 19, 2025 (GLOBE NEWSWIRE) — Hard work, resilience, and relentless execution–these qualities define TA's Toronto Director of Business Development, Veronica Garcia, and Vice President of Managed Transportation, Cross-Border Services, and LTL, Mike Teresinski. That's why TA, a leading North American third-party logistics provider (3PL), announces today their recognition among the industry's elite.

(NYSE:TFII), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In TFI To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in TFI between April 26, 2024 and February 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner

Nebula Legal is excited to bring a completely fresh ediscovery.com website experience to the legal technology market, empowering both users and prospective buyers alike. Nebula Legal (ai.ediscovery.com) has launched a redesigned ediscovery.com website, significantly enhancing the visitor experience and providing more comprehensive information about the Nebula eDiscovery platform. The updated site offers a fresh, modern

Kastle Systems, the industry leader in managed security solutions and services, today announced a strategic investment into i2G Systems, a leading provider of advanced security solutions with a strong presence in data centers and experience in the highest-security industries, including healthcare, financial services, higher education, stadiums and arenas. https://mma.prnewswire.com/media/618274/Kastle_Systems_Logo.jpg This investment strengthens Kastle's ability to

Alchemy Ventures Expands its New York City Portfolio, Securing a Prime Mixed-Use Property in One of Manhattan's Most Dynamic Neighborhoods Alchemy Ventures, an affiliate of Alchemy Properties Inc., has officially acquired 151 Avenue A, a 9,634-square-foot mixed-use property situated in the heart of New York City's East Village. The five-story building, which features eight three-bedroom,

“As a pastor, I wanted to create a new clericalt-shirt that would provide a liturgical layered look, yet would be casual, practical, and comfortable,” said an inventor, from Normal, Ill., “so I invented the CLERICAL T-SHIRT. My design eliminates the need for buttons, tabs, studs, or any type of attachment for the clerical collar.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg

“I wanted to create an elevated and eye-catching way for a motorcyclist to boldly display brake lights, turn signals, advertising, personal art, and other information,” said an inventor, from Burlington,N.C., “so I invented the HELMET SCREEN. My design would allow others to quickly determine when the motorcyclist is decelerating and changing lanes to avoid rear-end

Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across industries, announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management. The transformative solution leveragesagentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical